Daiki Kato

19PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMedical roboticsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 15, 2026
Correction: Iinuma et al. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. J. Clin. Med. 2021, 10, 5325.

|May 27, 2023
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

Fumiya Sugino, Keita Nakane, Makoto Kawase

|Mar 28, 2023
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer.

Shinichi Takeuchi, Koji Iinuma, Keita Nakane

|Feb 11, 2023
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.

Koji Iinuma, Toyohiro Yamada, Koji Kameyama

|Dec 23, 2022
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study.

Koji Iinuma, Risa Tomioka-Inagawa, Koji Kameyama

|Dec 22, 2022
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan.

Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa

Pageof 4

Frequent Collaborators

19 joint publications

Takuya Koie

10 joint publications

Koji Iinuma

9 joint publications

Kimiaki Takagi

7 joint publications

Tomoki Taniguchi